Stroke is a leading cause of death and adult
disability in the world. The second most prevalent type of stroke, known both
as intracerebral hemorrhage (ICH) and hemorrhagic stroke (HS) has the poorest
prognosis of all stroke subtypes and is responsible for about 40 percent of all
stroke deaths. However, there are
currently no drugs available to treat ICH, as the mechanisms behind the brain
damage caused by ICH have been only partially understood.
Researchers at the University of New Mexico have been
studying mechanisms of brain damage in ICH/HS and have some important
discoveries regarding the molecular process of ICH/HS-induced brain injury.
Consequently, they have identified novel small molecules to prevent brain
tissue damage. These molecules show benefits using both in vitro and in vivo ICH/HS
models offering a new potential approach for reducing brain damage.
potential target for reducing brain damage following intracerebral hemorrhage.
STC has filed intellectual property on this exciting new technology and
is currently exploring commercialization options. If you are interested
in information about this or other technologies, please contact Arlene
Mirabal at firstname.lastname@example.org or 505-272-7886.